Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Harmony Biosciences Holdings, Inc.
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
714.38 |
841.82 |
991.43 |
1,157.52 |
1,407.23 |
1,650.38 |
Przychód Δ r/r |
0.00% |
17.84% |
17.77% |
16.75% |
21.57% |
17.28% |
Przychód (min) |
714.34 |
817.25 |
933.77 |
1,157.52 |
1,356.07 |
1,590.38 |
Przychód (max) |
714.41 |
866.39 |
1,048.10 |
1,157.52 |
1,457.41 |
1,709.23 |
EBITDA (średnia) |
199.00 |
234.49 |
276.17 |
322.43 |
391.99 |
459.72 |
EBIT (średnia) |
162.60 |
191.60 |
225.65 |
263.46 |
320.29 |
375.63 |
EBIT % |
22.76% |
22.76% |
22.76% |
22.76% |
22.76% |
22.76% |
Zysk netto (średni) |
152.72 |
181.09 |
225.99 |
304.06 |
397.37 |
509.67 |
Zysk netto % |
21.38% |
21.51% |
22.79% |
26.27% |
28.24% |
30.88% |
EPS (średnia) |
2.36 |
3.13 |
4.01 |
4.93 |
6.87 |
8.81 |
Liczba analityków (Przychody) |
6 |
5 |
8 |
6 |
2 |
5 |
Liczba analityków (EPS) |
6 |
3 |
5 |
6 |
3 |
4 |
symbol |
HRMY |
HRMY |
HRMY |
HRMY |
HRMY |
HRMY |